Genmab — August 2012
-
-
han tager lidt tilløb og lidt på plus point kontoen ala jeg sagde det jo
-
Så taler vi om Duobody
-
så snakker han duobody
-
Det talte vi bare ikke om for 1 år siden
-
WILL recieve future milestones
-
Potential value 1,9 milliarder dollars
-
Janssen aftalen er meget større.
-
nemlig
-
Både Norvartis og Janssen betaler AL forskning
-
significant intererest
-
fra andre selskaber
-
vil lave flere aftaler i fremtiden
-
Duobody er ranked som den bedste bispecifikke antistof platform
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind